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Abstract
Background: Understanding the molecular control of cell lineages and fate determination in complex tissues is
key to not only understanding the developmental biology and cellular homeostasis of such tissues but also for our
understanding and interpretation of the molecular pathology of diseases such as cancer. The prerequisite for such
an understanding is detailed knowledge of the cell types that make up such tissues, including their comprehensive
molecular characterisation. In the mammary epithelium, the bulk of the tissue is composed of three cell lineages,
namely the basal/myoepithelial, luminal epithelial estrogen receptor positive and luminal epithelial estrogen
receptor negative cells. However, a detailed molecular characterisation of the transcriptomic differences between
these three populations has not been carried out.
Results: A whole transcriptome analysis of basal/myoepithelial cells, luminal estrogen receptor negative cells and
luminal estrogen receptor positive cells isolated from the virgin mouse mammary epithelium identified 861, 326
and 488 genes as highly differentially expressed in the three cell types, respectively. Network analysis of the
transcriptomic data identified a subpopulation of luminal estrogen receptor negative cells with a novel potential
role as non-professional immune cells. Analysis of the data for potential paracrine interacting factors showed that
the basal/myoepithelial cells, remarkably, expressed over twice as many ligands and cell surface receptors as the
other two populations combined. A number of transcriptional regulators were also identified that were
differentially expressed between the cell lineages. One of these, Sox6, was specifically expressed in luminal
estrogen receptor negative cells and functional assays confirmed that it maintained mammary epithelial cells in a
differentiated luminal cell lineage.
Conclusion: The mouse mammary epithelium is composed of three main cell types with distinct gene expression
patterns. These suggest the existence of a novel functional cell type within the gland, that the basal/myoepithelial
cells are key regulators of paracrine signalling and that there is a complex network of differentially expressed
transcription factors controlling mammary epithelial cell fate. These data will form the basis for understanding not
only cell fate determination and cellular homeostasis in the normal mammary epithelium but also the contribution
of different mammary epithelial cell types to the etiology and molecular pathology of breast disease.
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The function of complex tissues, such as the mammary
epithelium, is a product of the interactions between their
constituent cell types. In such tissues, disease states like
cancer are essentially a failure of this cellular homeostasis
and are characterised by insensitivity of cells to external
regulatory factors and aberrant cell fate choices. Under-
standing the molecular regulation of the individual cell
types in complex tissues is, therefore, a prerequisite for
understanding disease states. Furthermore, advances in
molecular pathology have demonstrated that different
disease phenotypes correlate with different gene expres-
sion profiles [1]. In a complex tissue, composed of differ-
ent cell types with different molecular characteristics, the
gene expression profiles of different diseases may reflect
the contribution of different cell types to that disease.
Therefore, a detailed molecular characterisation of the cell
types in a complex tissue is essential for the interpretation
of the molecular pathology of its diseases.
The resting adult mammary epithelium consists of two
main structures, alveoli (which develop into milk-secret-
ing lobulo-alveolar structures upon pregnancy) and ducts
(which carry the milk from the lobulo-alveolar structures
to the nipple) [2]. These two structures are themselves
composed of two main epithelial cell layers, basal cells
and luminal cells. The basal cell layer mainly consists of
myoepithelial cells which contract in response to oxytocin
release during lactation to force milk down the ducts to
the nipple. Recent work has demonstrated that the basal
cell layer also contains the mammary epithelial stem cell
compartment [3-7]. The luminal cell layer has been
shown to be composed of two functionally distinct line-
ages defined by expression of the cell surface proteins
CD24 and Sca-1. CD24+/High Sca-1+ luminal cells express
estrogen receptor alpha (ER), as well as receptors for pro-
lactin and progesterone (the luminal ER+ compartment),
while CD24+/High Sca-1- luminal cells (the luminal ER-
compartment) express genes (at low levels) for milk pro-
teins even in the virgin and likely include alveolar progen-
itors [5,7-9].
Although it is known that the stem cells can generate all
the myoepithelial, luminal ER- and luminal ER+ daughter
cell types [5], the mechanisms which control cellular
homeostasis, fate determination and lineage commitment
in the mammary epithelium are poorly understood. They
are likely to be a product of complex interactions between
cell extrinsic paracrine influences, cell intrinsic transcrip-
tional regulators and epigenomic modifications [10].
Some progress has been made towards understanding
some of the cell intrinsic factors involved. For instance,
Gata3 was recently identified as a transcription factor
important in specifying commitment in the general lumi-
nal lineage [11,12] and Elf5 was shown to be a specifier of
alveolar cell fate [13]. A number of the cell extrinsic (para-
crine) factors operating within the mammary epithelium
have also been characterised, such as Wnt-4, which acts
downstream of progesterone signalling in ductal side-
branching [14] and the EGF-family member Amphiregu-
lin [15,16], which is produced by ER+ cells in response to
estrogen and stimulates mammary stem cell activity (most
likely acting indirectly via non-epithelial cells and addi-
tional paracrine factors) [17]. The Notch signalling path-
way has also been shown to be an important determinant
of luminal cell fate [18,19]. However, the full extent and
nature of paracrine interactions in the mammary gland,
and the degree to which the different lineages contribute
to them, and are defined by them, is still not fully under-
stood.
Gene expression patterns have been previously examined
in the mouse mammary gland, either as changes in gene
expression across the whole tissue in developmental time-
courses [20,21] or as comparisons between the total epi-
thelium and the mammary stroma [12]. In one report,
gene expression patterns were examined in mouse lumi-
nal and myoepithelial cells purified by flow sorting as well
as in stem cell enriched basal cell populations [6]. How-
ever, these stem cell gene signatures were found to be not
significantly different from the myoepithelial signatures,
suggesting they were derived from cell populations domi-
nated by myoepithelial cells. The purity of the basal stem
cell populations remains a persistent problem due the dif-
ficulty of isolating pure (as opposed to enriched) stem cell
fractions. A number of gene expression studies have also
been carried out on human breast cells. The response of
human breast epithelium to estrogen has been analysed at
the gene expression level in breast cancer cell lines in vitro
and as xenografts [22-24], in normal breast tissue main-
tained as xenografts [25] and in normal human ER+ breast
cells isolated by transduction of primary breast epithelial
cells with a virus carrying an estrogen response element
driving GFP expression [26]. The comparative gene
expression profiles of normal human myoepithelial
[27,28], basal non-myoepithelial (with a cell surface phe-
notype CD10- CD44+) [29] and luminal epithelial cells
[27-29] have also been examined, as have the gene expres-
sion profiles of different in vitro progenitor (colony-form-
ing) subpopulations of normal breast epithelial cells [18].
However, to date no genome-wide transcriptome study
has made a direct comparison between the two luminal
epithelial populations (ER- and ER+) and the basal/
myoepithelial cells, confounding the molecular character-
isation of the luminal cells and preventing the analysis of
the lineage commitment of, and interactions between, the
two luminal cell types and the other cell types in the
gland.
The aim of this study, therefore, was to carry out the first
comprehensive gene expression study which examined
gene expression patterns in the three distinct mouse mam-Page 2 of 28
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nal ER- and luminal ER+. The analysis was to concentrate
on three specific areas. First, characterising cell-type spe-
cific patterns of gene expression which defined cell iden-
tity. Second, establishing a broad overview of the likely
extent and nature of paracrine interactions amongst the
populations. Last, defining cell intrinsic factors which
may be important in determining lineage commitment
and cell fate in the mammary epithelium. The results of
these analyses have, first, identified a novel potential
function for a subpopulation of mammary luminal epi-
thelial cells as non-professional immune cells; second,
provided information on the large number of paracrine
interactions yet to be fully characterised in the mammary
gland and the likely complexity of their interactions;
third, identified population-specific transcription factors
which may have a role in lineage determination and fate
specification in the mammary epithelium. In particular,
we have used in vitro and in vivo functional analyses to
demonstrate that Sox6 is a determinant of luminal cell
fate.
Results
Identification of population-specific gene expression 
patterns in the virgin mouse mammary epithelium
To carry out a comprehensive, whole genome gene expres-
sion analysis of the epithelial cell populations in the vir-
gin mammary gland (Figure 1A and 1B), primary mouse
mammary cells were isolated and stained with anti-CD24
and anti-Sca-1 antibodies. The CD24+/Low Sca-1-, CD24+/
High Sca-1- and CD24+/High Sca-1+ cells were separated by
flow cytometry (Figure 1C) and used to prepare RNA. To
demonstrate that these populations corresponded to
basal/myoepithelial, luminal ER- and luminal ER+ cells
respectively, as we have previously described [5], relative
gene expression levels of the basal cell marker Keratin 14
(Krt14), the luminal cell marker Keratin 18 (Krt18) and
Estrogen Receptor α (Esr1) were measured by quantitative
real-time rtPCR (qPCR). The results showed that the
CD24+/Low Sca-1- cells expressed Krt14 but not Krt18 and
that the CD24+/High Sca-1- and CD24+/High Sca-1+ cells
expressed Krt18 but not Krt14. They also showed that the
CD24+/High Sca-1+ population was enriched for Esr1
expression compared to the other two populations. This
agreed with previous data [5] and with staining of sections
through the mouse mammary gland (Figure 1A and 1B)
which showed that the basal cells were Keratin 14+ (K14+),
the luminal cells were K18+ and that ER+ cells were found
exclusively in the K18+ luminal cell layer. Therefore, these
data confirmed the identity of the three populations [see
Additional file 1] [5]. Next, a whole transcriptome gene
expression analysis of the three populations was carried
out using the Affymetrix platform (Mouse Expression
Arrays MOE430 2.0). To identify genes whose expression
in one population was different from its expression in the
other two, Significance Analysis of Microarray (SAM) was
applied [30,31]. Using this technique in a multiclass set-
ting, the average gene expression within one group was
compared with the average gene expression of all samples.
Following repeated permutation of the data, the strength
of the relationship between gene expression and its
expressed group was established and a significance level
determined. When a FDR cutoff of 0.0% was applied,
2182 probe sets [see Additional file 2] were identified
which showed significant differential expression across
the three populations. These 2182 probes corresponded
to 1427 well known individual genes. Heat mapping and
hierarchical cluster analysis of the genes identified 14 dif-
ferent gene clusters. The cluster analysis showed that some
gene sets were characteristic of only one population (e.g.
clusters 1, 10 and 11) whereas others were expressed in
two of the three (e.g. cluster 14) (Figure 2) [see Additional
file 3].
To identify genes whose expression characterised the three
subpopulations, the list of genes was split into three sets
on the basis of relative abundance of expression. Any gene
with a relative abundance of 2 or higher in a population
was considered as population-specific. If a gene was repre-
sented by more than one probe set, the average of all
probe sets was used for further analysis. This analysis
identified 861, 326 and 488 genes as characteristic of
basal/myoepithelial cells, luminal ER- cells and luminal
ER+ cells, respectively [see Additional files 4, 5, 6]. To con-
firm our approach, a subset of genes specific for each of
the three populations, as well as some which were com-
mon to two of the populations, were selected for qPCR
validation. Furthermore, a number of genes previously
shown to be relevant in mammary biology were included
in this analysis, as was the data collected on Krt14, Krt18
and Esr1 expression in the populations [see Additional
file 1], giving 58 genes in total (Figure 3). The qPCR
probes for 3 genes failed to amplify any product in any of
the populations. For a further 10 genes, there was no dif-
ferential expression pattern in the array analysis. Techni-
cal problems, such as poor signal strength from the
Affymetrix probe, cannot be ruled out in these cases. Of
the remaining 45 genes which showed a differential
expression pattern in both the array and qPCR analyses,
40 genes (88.9%) showed identical expression patterns
across the three populations in both sets of data. With
only 5 genes (11.1%) was the pattern of differential
expression suggested by the array data different to that
suggested by the qPCR analysis [see Additional file 7].
Overall, therefore, the qPCR data showed that the gene
expression array dataset could be relied upon for a global
picture of the biology of the three populations.
Comparisons with previously published datasets
We compared our data with previous studies which have
used a cell separation approach to isolate mouse [6] or
human [27-29] mammary epithelial basal/myoepithelialPage 3 of 28
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CD24 and Sca-1 expression distinguishes basal, luminal ER- and luminal ER+ mammary epithelial cellsFigure 1
CD24 and Sca-1 expression distinguishes basal, luminal ER- and luminal ER+ mammary epithelial cells. A) Sec-
tion through a branching duct in a mouse mammary gland stained for expression of keratin 14 in the basal myoepithelial layer 
(K14; red) and keratin 18 in the luminal epithelial layer (K18; green) and counterstained with DAPI (blue) to distinguish nuclei. 
Bar = 60 μm. B) Section through a mouse mammary duct stained for K14 (red) and ER (green) and counterstained with DAPI. 
Only a subset of luminal cell nuclei show ER staining (examples indicated by arrows). Bar = 25 μm. C) Flow cytometry plots of 
freshly isolated mouse mammary epithelial cells stained with control IgG (left) or anti-CD24 and anti-Sca-1 (right) antibodies. 
The regions corresponding to the CD24+/Low Sca-1- (red), CD24+/High Sca-1- (green) and CD24+/High Sca-1+ (blue) populations 
are indicated.
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Partial heat map and cluster analysis of differential gene expression across virgin mammary epithelial populationsFigure 2
Partial heat map and cluster analysis of differential gene expression across virgin mammary epithelial popula-
tions. Clusters representative of the different gene expression patterns are shown. Red indicates high expression, green indi-
cates low expression [see Additional file 3].
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qPCR analysis validates gene expression array analysis of virgin mammary epithelial cell gene expressionFigure 3
qPCR analysis validates gene expression array analysis of virgin mammary epithelial cell gene expression. Data 
from qPCR analysis of expression of 55 genes in triplicate independent samples of basal/myoepithelial cells, ER- luminal cells and 
ER+ luminal cells. Each data point is the mean level of expression, ± 95% confidence intervals, across the three samples of that 
population relative to the comparator sample. A 'round robin' comparison analysis was used as described in the Methods. 
Genes determined by this method to be characteristic of the comparator population are indicated below each pair of graphs.
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ing, to identify genes found in common between these
datasets and our own data [see Additional files 8, 9, 10].
There was good concordance between the genes identified
in our data and that of Stingl and colleagues [6] in their
study of separated mouse epithelium. They identified 128
probes, corresponding to 80 well-annotated genes, signif-
icantly upregulated in their myoepithelial/mammary
stem cell enriched cell fraction compared to their mam-
mary colony forming cells (corresponding to the luminal
cell fraction). Of these 80 genes, 49 (61%) were signifi-
cantly enriched in our basal/myoepithelial cell dataset,
three were enriched in both the basal/myoepithelial cells
and the luminal ER+ cells and two were enriched in both
the basal/myoepithelial cells and the luminal ER- cells [see
Additional files 8 and 9]. Conversely, Stingl and col-
leagues identified 102 probes, corresponding to 66 well-
annotated genes, significantly downregulated in their
myoepithelial/mammary stem cell enriched cell fraction
compared to their mammary colony forming cells. Of
these, which would correspond to genes enriched in the
luminal epithelial fraction, none were enriched in our
basal/myoepithelial population but 28 (42%) were
enriched in both our luminal populations, five were
enriched only in the luminal ER- cells and four only in the
luminal ER+ cells [see Additional files 8 and 10]. However,
correspondence of our data with previously published
datasets from separated human cells [27-29] was lower,
although it tended to be better between the mouse
myoepithelial and human myoepithelial data sets than
between the luminal data sets from the different species
[see Additional files 8, 9, 10].
Interaction mapping of genes differentially expressed in 
mammary epithelial subpopulations identifies key 
processes and novel functions
To get a better understanding of the key biological proc-
esses occurring in each of the three cell types, we gener-
ated network interaction maps for the differentially
expressed genes [see Additional files 11, 12, 13]. Interac-
tion data derived from studies on human orthologues of
the genes identified were used to create the network maps,
as there is not enough data currently available purely from
studies of mouse genes to make such an analysis meaning-
ful.
When a basal/myoepithelial interaction map was con-
structed using both the differentially expressed genes and
genes interpolated by the network mapping program
(which allow connections to be extended and elabo-
rated), the resulting network was extraordinarily complex
(data not shown). For ease of interpretation, therefore, a
basal/myoepithelial network was constructed using only
direct interactions between genes characteristic of this cell
population, with no interpolations [see Additional file
11]. This network identified two major interaction 'mod-
ules' and three minor ones. Such interaction modules are
indicative of important processes occurring within a cell,
as they are composed of cell-type specific genes and
defined by multiple interactions between those genes. The
two major interaction modules can be broadly character-
ised as an extracellular matrix module including multiple
collagen genes and a cytoskeletal module including genes
for the keratins, vimentin, and genes whose protein prod-
ucts are involved in regulation of cell shape, movement
and contractility, such as the actin binding proteins
MYH10 [32] and TPM2 [33] and smooth muscle gamma
actin ACTG2 [34]. The minor modules indicated that the
basal/myoepithelial cell population also has important
processes based around Platelet-Derived Growth Factor
(PDGF), Ephrin and Insulin-Like Growth Factor (IGF1)
signalling. Ephrins are mediators of contact-dependent
communication between cells [35] whereas both PDGF
and IGF1 signalling are involved in paracrine cell-cell
communication [36,37].
The luminal interaction maps were built using both cell-
specific genes and interpolated genes [see Additional files
12 and 13]. As a result, it was less straightforward to define
cell-specific interaction modules which would indicate
the key cellular processes occurring in these cell types. We
therefore developed a mathematical approach to defining
the modules which required the assignment of network
hubs, node clusters and contiguous differentially
expressed network paths. To define network hubs (nodes
having multiple interactions), nodes were ranked by
descending connectivity. The minimum node connectiv-
ity in the top 10% of nodes was five for either network and
this was therefore set as a threshold for identifying hubs.
Differentially expressed hubs for the luminal ER- and ER+
networks are listed in Tables 1 and 2 respectively. There
was limited overlap between the luminal ER- and ER+ net-
work hubs with only three differentially expressed hubs
being shared (ERBB3, KRT18 and CD82). The majority of
hubs in both networks had a high content of physical
interactions with the exception of TNF, SP1, FAS, NFKB1
CREB1, EGR1 and SPI1, which are almost exclusively tran-
scriptional hubs. In the luminal ER- network TLR4, LY96,
ERBB3, MUC1 and CD82 were differentially expressed
hubs with significant clustering character, although the
strongest clustering was seen for the non-differentially
expressed hubs EGFR and ERBB2. Clustering was less pro-
nounced in the luminal ER+ network with PGR, ERBB3,
FGG, FGB, CD82 and COL8A1 forming significantly clus-
tered differentially expressed hubs. With the exception of
TLR4 and LY96 in the luminal ER- network, clustering and
connectivity were inversely correlated, with high connec-
tivity nodes such as ESR, PTN, CCL5, TNF and BCL2,
exhibiting very little or no clustering.Page 7 of 28
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approach was adopted [see Additional file 14]. Initially all
differentially expressed hubs were identified and, where
direct links existed between them in the network, these
were used to provide the backbone for each module. In
the second pass, modules were allowed to expand by the
addition of differentially expressed nodes with lower con-
nectivity (such that they did not qualify as hubs), if they
were directly linked to differentially expressed hubs. In
the third pass, non-differentially expressed hubs were
incorporated, if they were connecting at least two differen-
tially expressed hubs. This step allowed for bridging
between modules, providing further information about
their proximity and global topology within the luminal
ER- and luminal ER+ networks [see Additional files 15 and
16].
Following the initial two passes, four distinct modules
were established for the luminal ER- network [see Addi-
tional files 14 and 15]: the TLR (nodes TLR4, LY96 and
CD14), KIT (nodes KIT, ERBB3, LYN, TEC, GRB7, MUC1
and CD82), KRT (nodes KRT18 and KRT8) and BCL2
(nodes BCL2, BIK and BNIPL) modules (Table 3). Nodes
TNF, FAS, CCL5, CCL2 and RPS6KA5 were integrated in
the BCL2 subnet only at the third pass through a network
of transcriptional interactions, forming the TNF/FAS
module [see Additional file 14]. In addition, the KRT
module merged into the KIT module at this stage. The TLR
and KIT modules contained predominantly physical inter-
actions whereas the TNF/FAS module displayed a very
strong transcriptional character (82%). The three modules
exhibit topological proximity, defining a single subnet-
work with 39 connections and 27 nodes [see Additional
files 14 and 15]. Compared to the luminal ER- network
overall, this subnetwork showed higher clustering and,
whilst maintaining the average network connectivity, it
exhibited a significantly shorter mean shortest path and a
very low power exponent. Removing this subnetwork
from the overall luminal ER- network yielded a highly
fragmented graph ('non-module subnetwork') with no
clustering and very low connectivity [see Additional file
17].
For the luminal ER+ network, six distinct modules were
observed following the initial two passes [see Additional
files 14 and 16]: the ESR (nodes ESR1, PGR, GADD45G,
Table 1: Hubs and clustered nodes in the luminal ER- network.
Hub knode Cnode Differentially expressed 
neighbours
Physical interaction content Transcriptional interaction 
content
CCL5* 17 0.000 0 35% 65%
TLR4* 17 0.103 2 82% 18%
TNF* 15 0.000 0 13% 87%
BCL2* 14 0.000 2 60% 40%
LY96* 14 0.154 2 100% 0%
KIT* 13 0.013 3 92% 8%
CCL2* 10 0.000 0 40% 60%
LYN* 10 0.022 1 100% 0%
ERBB3* 9 0.194 3 100% 0%
SP1 9 0.000 8 0% 100%
FAS* 8 0.000 0 25% 75%
MUC1* 8 0.143 1 100% 0%
GRB2 7 0.000 6 100% 0%
UBQLN4 7 0.000 6 100% 0%
CD82* 6 0.133 1 100% 0%
KRT18* 6 0.067 1 83% 17%
NFKB1 6 0.000 5 0% 100%
ATXN1 5 0.000 4 100% 0%
CD14* 5 0.100 2 40% 60%
CREB1 5 0.000 4 20% 80%
EGFR 5 0.300 4 100% 0%
ERBB2 5 0.300 4 100% 0%
MAPK1 5 0.000 4 100% 0%
PIK3R1 5 0.000 4 100% 0%
RPS6KA5* 5 0.000 0 100% 0%
SPI1 5 0.000 4 0% 100%
*Differentially-expressed genes. Knode, node connectivity, Cnode, node clustering coefficient, calculated as Cnode = 2 nnode/(knode (knode - 1)) where 
nnode is the number of interactions between the hub first neighbours. Hubs exhibiting clustering are shown in bold. High content of physical or 
transcriptional interactions in the hub is shown in bold.Page 8 of 28
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WFDC2), ERBB3 (nodes ERBB3, CD82 and GRB7),
MLLT4 (nodes MLLT4, EPHB6 and NRXN3), COL8A1
(nodes COL8A1 and EFEMP2), KRT (nodes KRT18 and
KRT8) and FGG (nodes FGG and FGB) modules (Table 3).
After the third pass, modules ESR, ERBB3, KRT, COL8A1
and MLLT4 were merged into a large subnetwork with dif-
ferentially expressed hubs TGFB1, AREG, MBP, CAV1,
EPS15 and PCDHA4 playing an interconnecting role [see
Additional file 14]. Unlike the luminal ER- network,
where all modules were proximal to each other, more
fragmentation was observed for the luminal ER+ network,
with module FGG and differentially expressed hubs
HIST1H4H, HIST1H4I and LNX1 not interconnected with
the module subnetwork via any other hubs. The luminal
ER+ subnetwork also had a much stronger physical inter-
action character than the luminal ER- subnetwork. Com-
pared to the overall luminal ER+ network, its subnetwork
showed high clustering and, whilst maintaining the aver-
age network connectivity, exhibited a significantly shorter
mean shortest path. As with the luminal ER- subnetwork,
removing the luminal ER+ subnetwork from the overall
luminal ER+ network gave a highly fragmented graph with
no clustering and very low connectivity [see Additional
file 17]. The luminal ER- and luminal ER+ modules, their
component nodes and potential functions are summa-
rised in Table 3. They suggest that the major processes
occurring in the luminal ER- cells are tyrosine kinase cell
signalling pathways in association with cellular cytoskele-
tal components (the keratins) as well as passive immune
signalling and inflammatory response processes. The pic-
ture in the luminal ER+ cells is less straightforward. There
is no obvious unifying theme to the major ESR module,
which leaves five minor modules involved in signal trans-
duction, the cytoskeleton, cell adhesion and maintaining
the extracellular matrix (although compared to the basal/
myoepithelial cells, the role of the luminal ER+ cells in this
is minor).
The TLR module within the luminal ER- network was of
particular interest (Figure 4) [38], as it indicated a novel
role of these cells as non-professional immune cells which
Table 2: Hubs and clustered nodes in the luminal ER+ network.
Hub knode Cnode Differentially expressed 
neighbours
Physical interaction content Transcriptional interaction 
content
ESR1* 27 0.020 3 53% 47%
PTN* 19 0.012 6 95% 5%
TGFB1* 17 0.000 0 47% 53%
HIST1H4H* 16 0.000 0 100% 0%
HIST1H4I* 16 0.000 0 100% 0%
GADD45G* 13 0.051 2 88% 12%
EFEMP2* 10 0.022 1 100% 0%
LNX1* 10 0.000 0 100% 0%
AREG* 9 0.000 0 44% 56%
CAV1* 9 0.000 0 78% 22%
EGFR 9 0.056 6 92% 8%
CRELD1* 8 0.000 1 100% 0%
KRT18* 8 0.036 1 89% 11%
PGR* 8 0.143 1 63% 37%
SP1 8 0.036 6 0% 100%
EPS15* 7 0.000 0 100% 0%
ERBB3* 7 0.143 2 100% 0%
FGG* 7 0.238 1 100% 0%
PCDHA4* 7 0.000 0 100% 0%
UBQLN4 7 0.048 3 100% 0%
FGB* 6 0.333 1 100% 0%
ATXN1 5 0.000 1 100% 0%
CD82* 5 0.200 1 100% 0%
CEBPB 5 0.000 1 20% 80%
COL8A1* 5 0.100 1 100% 0%
EGR1 5 0.000 1 0% 100%
ERBB2 5 0.200 3 100% 0%
MBP* 5 0.000 0 100% 0%
MLLT4* 5 0.000 2 100% 0%
SMAD2 5 0.000 2 100% 0%
TP53 5 0.000 2 80% 20%
See legend to Table 1 for details. *Differentially expressed genes.Page 9 of 28
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that the luminal ER- population was indeed enriched for
cells expressing components of the CD14-TLR4 signalling
complex, qPCR analysis of relative expression levels of the
three components of the LPS receptor, CD14, Ly96 and
Tlr4, its downstream effecter Irak2 and the LPS receptor
responsive gene Tnf were carried out [38]. The results (Fig-
ure 5) confirmed that all five genes were specifically
Table 3: Summary of modules from luminal networks
Module Constituent hubs Function Ref. Inferred module function
Luminal ER-
TLR CD14 Component of LPS receptor [38] Passive immune
LY96 Component of LPS receptor [38] response
TLR4 Component of LPS receptor [38]
KIT/KRT CD82 Tetraspanin [86] Kinase signalling
ERBB3 ERBB family tyrosine kinase [51] pathways and
GRB7 Signalling adaptor protein [87] cellular structural
KIT Receptor tyrosine kinase [88] integrity
KRT8 Cytoskeletal component [89]
KRT18 Cytoskeletal component [89]
LYN Src family kinase [90]
MUC1 Mucin family cell surface protein [91]
TEC Non-receptor tyrosine kinase [92]
TNF/FAS BCL2 Anti-apoptotic protein [93] Inflammatory
BIK Pro-apoptotic protein [94] response and cell
BNIPL Putative pro-apoptotic protein [95] death
CCL2 Inflammatory chemokine [96]
CCL5 Inflammatory chemokine [96]
FAS Prototype death receptor [97]
RPS6KA5 Serine/threonine kinase; controls transcriptional response to TNF [98]
TNF Pro-inflammatory cytokine [97]
Luminal ER+
ESR CRELD1 Cell adhesion molecule [99] Multifunctional
ESR1 Transcriptional regulator [56]
GADD45G DNA damage response [100]
GIPC2 Mediate cross-talk between cell signalling pathways [101]
KRT19 Cytoskeletal component [89]
MYCBP Interacts with Myc and A-kinase anchoring proteins [102]
PGR Transcriptional regulator [39]
PTN Activation of stromal fibroblasts and stimulation of angiogenesis [103]
STC2 Secreted glycoprotein with possible autocrine or paracrine function [104]
WFDC2 Secreted anti-microbial protein [105]
ERBB3 CD82 Tetraspanin [86] Signal transduction
ERBB3 ERBB family tyrosine kinase [51]
GRB7 Signalling adaptor protein [87]
MLLT4 EPHB6 Cell-cell interactions/adhesion [35] Cell adhesion
MLLT4 Cell adhesion [106]
NRXN4 Cell-cell interactions/adhesion [107]
COL8A1 COL8A1 Extracellular matrix protein [108] Generation of
EFEMP2 Extracellular matrix protein [109] extracellular matrix
KRT KRT8 Cytoskeletal component [89] Cellular structural
KRT18 Cytoskeletal component [89] integrity
FGG FGB Extracellular matrix protein [110] Generation of
FGG Extracellular matrix protein [110] extracellular matrixPage 10 of 28
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Network interaction map for luminal ER- specific genesFigure 4
Network interaction map for luminal ER- specific genes. Interaction data based on physical interactions (solid lines) and 
transcriptional interactions (dashed lines). The nodes are colour coded to indicate relative strengths of expression of the gene 
within the cell population. Brighter reds indicate highest levels of expression. Darker reds indicate genes less strongly 
expressed (although still with enriched expression within the population compared to the other cell types). White nodes indi-
cate interpolated genes used by the network mapping software to extend and link the network [see Additional file 12]. A) 
Whole interaction map. Box indicates Toll-like receptor module. B) Enlargement of Toll-like receptor interaction module.
BMC Genomics 2008, 9:591 http://www.biomedcentral.com/1471-2164/9/591enriched in the luminal ER- cells compared to both the
basal/myoepithelial and luminal ER+ cells. In particular,
CD14, Tlr4 and Tnf were expressed at 10-fold, 3-fold and
2-fold, respectively, higher levels in the luminal ER- cells
compared to the luminal ER+ cells. CD14 and Tnf were
expressed at 30-fold and 5-fold higher levels in the lumi-
nal ER- cells compared to the basal/myoepithelial cells.
Tlr4 expression was undetectable in the basal/myoepithe-
lial cells.
To determine whether CD14 expression, and thus the
potential to be able to respond to LPS, was a general prop-
erty of all luminal ER- cells or only a subfraction, freshly
isolated primary cells were stained with anti-CD24 and
anti-Sca-1 antibodies, to enable the three main cell com-
partments to be identified, as well as with anti-CD14 and
anti-CD61 (proposed as a marker of progenitor cells) [11]
antibodies. The results (Figure 6A) showed that the
CD24+/High Sca-1- luminal ER- population is itself com-
posed of four different subpopulations, namely CD14-
CD61- cells, CD14+ cells, CD61+ cells and CD14+ CD61+
cells. Interestingly, a small number of CD24+/Low Sca1-
basal cells also showed elevated levels of CD61 expres-
sion.
The luminal ER+ gene expression pattern is not an 
'estrogen-responsive' gene expression signature
Upon examination of the luminal ER+ gene network, we
noted that few of the genes enriched in the luminal ER+
population were directly linked to ESR1 by transcriptional
interactions, with the exception of the progesterone recep-
tor (PGR) [39] and the cytoskeletal protein keratin 19
(KRT19) [40]. This suggested that the gene signature of the
luminal ER+ cells was not an 'estrogen responsive' gene
signature. Rather, it was more likely to represent an under-
lying stable gene expression pattern characteristic of this
differentiated cell population. To investigate this further,
we compared lists of estrogen responsive genes reported
in studies of estrogen-stimulated normal human mam-
mary epithelial cells [25,26] and breast cancer cell lines
with our lists of genes expressed in the epithelial subpop-
ulations [22-24]. The results [see Additional file 18] con-
firmed that there was little correlation between 'estrogen-
responsive' signatures and the genes enriched in the lumi-
nal ER+ population. Indeed, many of the gene whose
expression was stimulated by estrogen in the breast cancer
cell lines were found to be enriched in our basal/myoepi-
thelial population. However, it should be noted that the
well-known directly estrogen responsive genes KRT19 and
PGR, were not found to be upregulated in most of the
published datasets.
Identification of basal/myoepithelial cells as key mediators 
of paracrine signalling
Having identified key processes likely to be occurring
within each of the three populations, we next investigated
how the populations might be interacting with each
other. Mammary epithelial biology is characterised by the
conversion of systemic hormone signals into local growth
factor signals which stimulate stem cell proliferation and
differentiation of daughter cell types. Whilst some of these
paracrine interactions have been studied in depth
[15,17,41], the broad extent of paracrine networks within
the mammary epithelium remains unknown. We there-
fore queried the gene expression array data for genes
potentially involved in paracrine signalling, either as
receptors or ligands (where there was a conflict between
the gene expression array and qPCR data, the distribution
predicted by the qPCR data was favoured). A number of
genes were identified which fulfilled these criteria [see
Additional file 19]. Remarkably, they showed that the
basal/myoepithelial cells have more than double the com-
plement of cell-surface receptors and ligands than either
of the two luminal populations. Of particular interest, the
basal/myoepithelial cells expressed the genes for the
Notch family ligands, Jag1, Jag2 and Dll1 [42] whilst the
gene for the Notch family receptor Notch3 [43] was
expressed in both the luminal populations. Wnt family
ligands were expressed by all three populations, although
each cell type expressed a different complement of Wnt
genes and only the basal/myoepithelial cells expressed the
genes for the Frizzled receptors [44].
It is well established that Egf receptor family members and
Egf family ligands are important for mammary gland
development and breast cancer [45,46]. In particular, the
paracrine role of Amphiregulin (Areg) is well described
[15,41,47,48]. Our analysis confirmed that luminal ER+
mammary epithelial cells expressed the Areg gene but also
showed that the genes for two other family members,
Betacellulin (Btc) [49] and Epigen (Epgn) [50], were
expressed in this cell type and Btc was also expressed in the
luminal ER- cells. Interestingly, only one Egf receptor fam-
ily member, Erbb3 [51], was found by gene expression
array and qPCR analysis to be differentially expressed in
the normal mammary epithelium. It was present in both
the luminal epithelial populations but not in the basal/
myoepithelial cells.
This analysis extends previous findings of paracrine sig-
nalling within the mammary epithelium and emphasises
the complexity of the interacting signalling networks.
These include Wnt and Notch signalling, the Egf family,
Fgf signalling, other receptor tyrosine kinases, G-protein
coupled receptors, ligands for such receptors, integrins
and ephrins/Eph receptors all of which are differentially
expressed between the cell populations. In particular, the
numbers of ligands and receptors expressed by the basal/
myoepithelial cells indicates that this population is a key
mediator of the paracrine signalling networks within the
mammary epithelium.Page 12 of 28
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qPCR analysis confirms that luminal ER- cells are enriched for expression of LPS receptor pathway genesFigure 5
qPCR analysis confirms that luminal ER- cells are enriched for expression of LPS receptor pathway genes. Data 
from qPCR analysis of CD14, Irak2, Ly94, Tlr4 and Tnf gene expression in triplicate independent samples of basal/myoepithelial 
cells, luminal ER- cells and luminal ER+ cells. Each data point is the mean level of expression, ± 95% confidence intervals, across 
the three samples of that population relative to the comparator sample. The 'round robin' comparison method and assignment 
of genes to the populations were carried out as described in the Methods.
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Identification of CD14+ and CD61+ cells in the luminal ER- population and confirmation of differential expression of transcrip-tio al regulatorsFigure 6
Identification of CD14+ and CD61+ cells in the luminal ER- population and confirmation of differential expres-
sion of transcriptional regulators. A) Flow cytometric analysis of virgin mouse mammary cells stained with anti-CD24 and 
a control IgG or anti-CD24 and anti-Sca-1, to define the myoepithelial/basal, luminal ER- and luminal ER+ populations. The stain-
ing patterns of the three populations with control IgGs or anti-CD14 and anti-CD61 is indicated. The percentages in the 
CD14/CD61 quadrants indicate the mean percentage (± SD; n = three independent sorts) of that epithelial subpopulation (not 
of the total epithelium) falling into that quadrant. B) qPCR analysis of expression of transcriptional regulators in mammary epi-
thelial subpopulations. Mean gene expression levels ± 95% confidence limits for the seventeen transcriptional factors indicated 
on the X-axis are given relative to the basal/myoepithelial population. The genes are grouped according to the cell popula-
tion(s) which has the strongest level of expression. If there is no data point for a population for a given gene, then that gene 
could not be detected in that population.
BMC Genomics 2008, 9:591 http://www.biomedcentral.com/1471-2164/9/591Identification of differentially regulated transcription 
factors within the mammary epithelium
Transcriptional regulators are key cell-intrinsic factors in
lineage selection and cell fate decisions in stem – differen-
tiated cell hierarchies [52,53]. Therefore, the gene expres-
sion array data set was interrogated to identify
differentially expressed factors which may regulate tran-
scription [see Additional file 19]. The expression of a sub-
set of these was analysed by qPCR (Figure 6B). As with the
potential paracrine interactions, the basal/myoepithelial
cells differentially expressed many more transcriptional
regulators (fifty-two) than the other two populations. The
ER- luminal cells differentially expressed twenty-one tran-
scription factors but only seven transcription factors were
differentially expressed in the luminal ER+ cells. Three
transcription factors were found to be expressed in both
the basal/myoepithelial and luminal ER- populations, one
was common to both the basal/myoepithelial and lumi-
nal ER+ cells and two were found in all three populations.
In common lineage progenitors, functional mutual
repression and auto-stimulation by transcription factors
can facilitate bilineage cell fate decisions [54]. Once the
cell fate decisions have been executed, continued function
of different subsets of the factors active in the progenitors
are required to maintain the different differentiated cell
lineages in stable fates [53]. Thus, modelling interactions
between lineage-specific transcription factors can eluci-
date cell fate decision processes occurring in progenitor
cells. Therefore, to begin to understand how interactions
between lineage specific transcription factors may influ-
ence cell fate choices in the mammary epithelium, an
interaction network was built. Transcription factors iden-
tified as lineage-specific but for which no interaction data
exists were excluded. The resulting network (Figure 7) was
centred around two main hubs, namely Myc and Esr1, sug-
gesting that they are key regulators of mammary cell fate
[55,56]. Clearly, a great deal of information exists on their
interactions and this would bias any interaction network
around these two key nodes. Nevertheless, the number of
(indirect) interactions that Myc makes with the basal-spe-
cific factors in particular suggests that it is a key factor in
regulating mammary cell fate determination. The small
number of luminal ER+ population specific factors and the
fact that three of them, Esr1, Pgr and Foxa1 [57], are
closely connected also supports a key role for the estrogen
receptor and its transcriptional network in regulating
luminal ER+ cell fate. As described above, however, the
luminal ER+ transcriptional profile is not, in general, an
estrogen responsive profile. Therefore, the activity of the
luminal ER+ specific transcription factors most likely leads
to long term stable cell fate changes and not changes
which are responsive to short-term fluctuations in estro-
gen signalling. Mutual repression and auto-stimulation
loops may be one way to achieve this long term stability.
Sox6 is a determinant of luminal cell fate
To demonstrate that the lineage specific transcription fac-
tors we identified can indeed influence cell fate and differ-
entiation, we chose to investigate in more detail the
function of Sox6 [52], the expression of which was only
detectable in one population, the luminal ER- cells (Figure
6B). Primary mouse mammary epithelial cells were trans-
duced in three independent experiments with either a
control lentivirus carrying GFP only or a virus carrying the
Sox6 gene plus GFP. The transduced cells were then split
between in vitro and in vivo assays.
For in vitro analysis, cells were cultured for one week and
then harvested, GFP+ cells were separated by flow cytome-
try and RNA isolated from them. The expression of Sox6,
Krt14, Krt18 and Esr1 was examined by qPCR and com-
pared to expression levels in cultured primary cells which
had not been transduced with virus. The data (Figure 8A)
demonstrated that Sox6 over-expression (approximately
800-fold over-expressed in Sox6 GFP virus-transduced
cells compared to non-transduced cells) did not signifi-
cantly alter Krt14 gene expression. However, Krt18 gene
expression was significantly increased in Sox6 over-
expressing cells compared to non-transduced cells or cells
transduced with the control virus (an approximately 3-
fold increase in expression levels). Esr1 expression levels
were also increased in Sox6 over-expressing cells, although
more modestly (1.7 fold; P < 0.05) [58]. Next, cultured
virus-transduced primary cells were stained for keratin 14
(K14) and keratin 18 (K18) expression. When primary
mouse mammary cells are isolated and grown in short-
term culture, the majority of cells which proliferate are
derived from the luminal epithelium. Within 48 hours in
culture, these luminal origin cells (which are K14- K18+ in
vivo) begin to promiscuously express K14 and acquire a
K14+ K18+ phenotype [59-61]. It is thought that this rep-
resents a de-differentiation event resulting from the cells
being removed from their normal environment [62].
Unsurprisingly, therefore, when non-transduced (GFP-)
and control transduced primary cells were stained for K14
and K18 expression, they were found to be both K14+ and
K18+. However, Sox6 transduced cells were K18+ but
showed only weak K14 staining in occasional cells (Figure
8B) [see Additional file 20]. Therefore, Sox6 maintained
mammary epithelial cells in the luminal epithelial lineage
and blocked promiscuous K14 protein expression in vitro.
However, as Sox6 over-expression did not block Krt14
gene expression, this cannot be a direct effect on Krt14
transcription.
For in vivo analysis, cells transduced with either GFP-only
or Sox6-GFP virus were transplanted into cleared mouse
mammary fat pads. After eight weeks, the transplanted fat
pads were examined (Figure 9A). In nine out of eighteen
fat pads transplanted in three independent experimentsPage 15 of 28
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BMC Genomics 2008, 9:591 http://www.biomedcentral.com/1471-2164/9/591with cells transduced with the GFP-only virus, extensive
mammary epithelial outgrowths were seen in which both
ducts and alveolar buds were GFP labelled. However, no
outgrowths were observed in twenty fat pads transplanted
in three independent experiments with cells carrying the
Sox6-GFP, although in two cases, cyst-like GFP-labelled
structures were observed.
It was not possible to determine at the wholemount level
whether fat pads which did not have extensive GFP+ out-
growths contained scattered GFP-labelled cells incorpo-
rated into non-GFP epithelium. Therefore, transplanted
fat pads were processed to single cells, labelled with anti-
Sca-1 and anti-CD24 antibodies and analysed by flow
cytometry to identify GFP+ cells and determine which of
the mammary epithelial cell populations they segregated
with (Figure 9B, C). Transplanted fat pads from two exper-
iments were pooled for this analysis whilst fat pads from
the third transplant experiment were analysed independ-
ently. As expected, GFP+ cells could be detected in the
preparations derived from these control fat pads (Figure
9B). These control GFP+ cells mainly segregated with the
CD24+/High Sca-1- luminal ER- population, although they
could also be found in the CD24+/Low Sca-1- basal/myoep-
ithelial and CD24+/High Sca-1+ luminal ER+ cells (Figure
9C). However, GFP+ cells could also be detected in prepa-
rations of cells from Sox6 GFP virus transplants (Figure
9B). Although only low numbers of GFP+ cells were
present, their distribution was shifted towards the CD24+/
High Sca-1+ luminal ER+ population (Figure 9C).
Interaction mapping of differentially expressed transcriptional regulators suggests Esr1 and Myc control the balance between basal and lu inal differentiationFigure 7
Interaction mapping of differentially expressed transcriptional regulators suggests Esr1 and Myc control the 
balance between basal and luminal differentiation. Interaction map generated using in-house ROCK database and then 
manually curated. Genes are colour-coded as indicated. Interaction data based on physical interactions (solid lines) and tran-
scriptional interactions (dashed lines).Page 16 of 28
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Sox6 over-expression maintains luminal differentiation in mammary epithelial cells in vitroFigure 8
Sox6 over-expression maintains luminal differentiation in mammary epithelial cells in vitro. A) qPCR analysis of 
Krt14, Krt18, Esr1 and Sox6 expression levels (mean levels from three independent experiments ± 95% confidence intervals) in 
cells transduced with virus expressing GFP only (light grey bars) or expressing both Sox6 and GFP (dark grey bars) compared 
to non-infected cells (open bars). B) Immunofluorescence staining for keratin 14 (upper two rows) and keratin 18 (lower two 
rows) expression in primary mouse mammary epithelial cells transduced with lentivirus expressing GFP only or Sox6 and GFP. 
Bars = 30 μm. Arrows indicate keratin positive cells in the Sox6 transduced cultures. These are common in the K18 stained 
cells but rare and only weakly stained in the K14 stained cells [see Additional file 20].
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We have described a comprehensive transcriptome analy-
sis of three distinct mammary epithelial cell populations,
basal/myoepithelial cells, estrogen receptor negative
luminal epithelial cells and estrogen receptor positive
luminal epithelial cells [5,8]. These data provide new sup-
port for the distinct identities of these three populations
and, in particular, justify distinguishing between two
major subpopulations within the luminal epithelium. We
have termed these luminal ER- and luminal ER+ cells as it
is expression of the estrogen receptor which makes them
most easily distinguishable in tissue sections (Figure 1).
However, each of them expresses, in addition, a large
number of unique genes which must be of relevance to
their in vivo functions. It is also clear that there are genes
in common to the two luminal populations but which are
not expressed by the myoepithelial cells. Expression of
these genes, for cytoskeletal proteins (e.g. keratin 18) or
tight junction components (e.g. claudins), for instance,
must reflect common aspects of luminal epithelial cell
function. Most obviously, they are for proteins important
in maintaining the structure of the luminal cell layer and
the integrity of the lumen itself.
Comparison of our data set with other published data sets
for separated myoepithelial and luminal cells
[6,26,27,29] showed good concordance between genes
previously identified as enriched in mouse mammary
myoepithelial and luminal cells [6]. However, there was
less agreement with genes previously identified as
enriched in human myoepithelial and luminal cells. A
number of factors are likely to contribute to these differ-
ences. Clearly, species differences could be important. For
instance, it is known that while K14 is a basal/myoepithe-
lial cell marker and K18 a luminal epithelial cell marker
throughout the mouse mammary epithelium and in the
ducts of the human breast, in the Terminal Ductal Lobu-
loalveolar Units of the human breast, K14 can be
expressed by the luminal epithelial cells [63]. Further-
more, technical differences could influence the outcome
of the analyses. In particular, it should be noted that Stingl
and colleagues used the same Affymetrix platform as our-
selves for their mouse analysis [6]. Finally, comparing
three distinct populations against each other, rather than
just two, improves the contrasts between the populations
and enables more population specific genes to be
detected. For example, a gene which is present in the
basal/myoepithelial cells and one of the luminal popula-
tions, but not the other, may not be detected as being sig-
nificantly differentially expressed when only
myoepithelial and total luminal cells are compared. How-
ever, when all three populations are compared against
each other, the contrast with the luminal population from
which the gene is absent enables the differential expres-
sion of the gene to be detected.
A novel functional cell type in the mammary epithelium
The nature of the luminal ER- population as a discrete
entity has been confirmed by its uniform staining profile
with the 33A10 antibody [8]. However, this population
appeared to contain within it further distinct functional
cell types. Use of network interaction mapping on the
transcriptomic profiles of the luminal ER- cells identified
a Toll-like receptor (TLR) signalling module including
genes for the three components of the bacterial lipopoly-
saccharide (LPS) receptor, Tlr4, CD14 and Ly96, as well as
downstream transducers of Toll-like receptor signalling
such as Irak2 and the pro-inflammatory cytokine Tnf,
which is a TLR signalling target [38] (Figure 4 and 5). Flow
cytometric analysis of the mammary epithelium using
anti-CD14 and anti-CD61 (a mammary progenitor cell
marker) [11] identified a small number of CD61+ cells in
the CD24+/Low Sca-1- basal population and four distinct
subpopulations within the luminal ER- cells, namely
CD61+, CD61+ CD14+, CD14+ and double negative cells.
This raises the possibility of a differentiation hierarchy in
which basal stem cells generate basal CD61+ progenitors
which then become CD61+ progenitors with luminal
characteristics. These then either lose CD61+ and become
the double negative cells (although presumably express-
ing other markers as yet undefined) or first acquire CD14
expression, becoming CD61+ CD14+ progenitors, and
then lose CD61 expression to become the CD14+ popula-
tion. If this hypothesis is correct, it suggests that the lumi-
nal ER- population contains two distinct functional cell
types, the double negative cells and the CD14+ cells.
The function of the double negative cells remains unclear.
However, given that the expression of all components of
the LPS receptor can be found in the luminal ER- popula-
tion, it is likely that the CD14+ cells have a distinct func-
tion within the mammary epithelium as non-professional
immune cells. Note that CD45+ cells were excluded from
this analysis, so these are unlikely to be contaminating
haematopoietic cells. Milk is an excellent growth medium
for bacteria and it would be evolutionarily advantageous
to have a cell type present in the breast capable of indicat-
ing the presence of bacterial contamination through Toll-
like receptor signalling pathways. However, it is also likely
that over-stimulation of this pathway in CD14+ mammary
epithelial cells would lead to serious inflammation and
would therefore be the cause of mastitis.
The presence of the distinct subpopulations within the
luminal ER- cells indicates that the gene expression profile
of this population is derived from a mixture of different
cell types. However, as the luminal ER- cells do all share at
least one distinctive marker (high levels of expression of
the epitope bound by the 33A10 antibody) [8] it is likely
that the luminal ER- profile includes genes whose expres-
sion is common to all the cells of this subpopulation, asPage 18 of 28
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Sox6 over-expression maintains luminal differentiation in mammary epithelial cells in vivoFigure 9
Sox6 over-expression maintains luminal differentiation in mammary epithelial cells in vivo. A) Wholemounts of fat 
pads transplanted with mammary epithelial cells transduced with control virus (left) or Sox6 GFP virus (right). Arrows indicate 
regions magnified in insets (GFP+ duct and alveolar buds in control gland; cyst-like structure in Sox6 gland). Bar = 225 μm. B) 
Flow cytometric analysis of GFP expression in non-infected, wild type cells (left), cells prepared from control transplanted fat 
pads (centre) and cells prepared from Sox6 transplanted fat pads (right). The lower set of histograms are magnifications of the 
corresponding upper histograms to show the GFP+ cells with greater clarity. C) Anti-CD24 and anti-Sca-1 staining pattern of 
cells prepared from control transplanted fat pads (upper plots) and Sox6 transplanted fat pads (lower plots). The plots for the 
total cells isolated from the transplanted fat pads and the GFP- and GFP+ fractions of cells isolated are shown. The CD24+/Low 
lSca-1-, CD24+/High Sca-1- and CD24+/High Sca-1+ regions are indicated as are the percentages of GFP+ cells in these regions.
BMC Genomics 2008, 9:591 http://www.biomedcentral.com/1471-2164/9/591well as genes expressed in subsets of its cells. The basal/
myoepithelial cell population is also a mixed population.
However, > 90% of these cells express both keratin 14 and
α-isoform smooth muscle actin and are thus differenti-
ated myoepithelial cells [5]. Therefore, the gene expres-
sion profile of this population is largely a myoepithelial
cell profile. The luminal ER+ population is also unlikely to
represent a completely uniform cell population but as the
majority of the cells are strongly keratin 18 positive and
express the estrogen receptor [5], the gene expression pro-
file of this population will be dominated by this single cell
type.
Myoepithelial cells are key regulators of paracrine 
signalling
Transcriptome and network interaction analysis of the
basal/myoepithelial cells identified key processes of these
cells as cytoskeletal function and extracellular matrix pro-
duction and interactions. Given what is known about the
contractile function of these cells in lactation and their
position in the mammary gland between the luminal epi-
thelium and the basement membrane around the ducts
and lobulo-alveolar structures, these results were reassur-
ing. However, what was remarkable was that the genes
characteristic of this population included more than dou-
ble number of genes for proteins involved in cell – cell sig-
nalling than were characteristic of the two luminal
populations combined. This suggests a key role for
myoepithelial cells in mediating paracrine and juxtacrine
cell – cell interactions in the mammary epithelium. Of
particular interest were the expression patterns of Wnt and
Notch signalling pathway components, known to be
important in mammary gland development [64,65],
which suggested a directionality of Notch signalling from
basal to luminal and a directionality of Wnt signalling
from luminal to basal. Notably, Notch signalling was
recently shown to be important for determining luminal
cell fate [19], possibly through regulation of luminal pro-
genitors [18]. Activated Wnt signalling has also been
shown to increase the stem/progenitor fraction of basal
mammary epithelial cells in MMTV-Wnt1 transgenic mice
[3].
Another gene from a family important for mammary
development that, like Notch3, was expressed in both the
luminal populations but not the basal/myoepithelial cells
was Erbb3. A member of the epidermal growth factor
receptor family, Erbb3 most effectively binds the neureg-
ulins Nrg1 and Nrg2, but it has no intrinsic signalling
activity of its own. It must therefore operate as a het-
erodimer with other family members. However, signalling
complexes containing Erbb3 have a strong propensity to
activate the phosphoinositide-3-kinase (PI3K) signalling
pathway due to the presence of six binding sites for the
p85 SH3 adaptor subunit of PI3K [51]. Erbb3 knockout
animals were embryonic lethal but reduction of Erbb3
expression in the mammary epithelium caused a reduc-
tion in terminal end bud numbers, branching and ductal
density [51,66]. Previous reports of Erbb3 expression have
been inconsistent [67,68], most likely due to variable
antibody quality, however, the ductal outgrowth defects
that occur when Erbb3 expression is reduced, together
with the observation that implantation of Nrg1-soaked
pellets induced ductal elongation at puberty [69], support
a role for Erbb3 in pubertal mammary development.
Whether or not Erbb3 activation has the same conse-
quences in both the luminal ER+ and luminal ER- cells
remains to be determined and may depend on differential
expression of dimerisation partners not detected by the
microarray assays.
Mammary epithelial cell subpopulations have distinct 
transcription factor profiles
Mutual interactions between transcription factors associ-
ated with different cell lineages and involving positive and
negative feedback loops have been demonstrated to be
able to maintain haematopoietic cells in a small number
of particular cell fates ('stable states') when an apparently
large number of potential intermediate fates are available
[54]. Transcription factors in the mammary epithelium
which have the potential to interact but which are appar-
ently expressed in different populations are therefore of
particular interest in the regulation of mammary epithe-
lial cell fate. We built a gene network to predict such inter-
actions and identified a number of these which are
potentially important. The most obvious is between Esr1
(luminal ER+) [56], Trp63 (basal) [70] and Myc (basal and
luminal ER-) [55] and given the large number of transcrip-
tion targets they share, it is likely that these three are key
factors in determining cell fate in the mammary gland.
However, there are also other interacting factors of interest
such as the Runx2 (basal) [71] – Msx2 (luminal ER+) [72]
pair, the Eya2 (basal) – Six4 (luminal ER-) pair [73] and
the Foxa1 (luminal ER+) [57] – AR (basal and luminal
ER+) [74] – Etv5 (basal) [75] triplet. Modelling these inter-
actions in order to make predictions about how transcrip-
tion factor behaviour determines mammary cell fate is an
important challenge for the future.
Sox6 is a determinant of luminal cell fate in the mammary 
gland
In order to model these interactions, functional data on
each individual factor will be required. Given the large
number of factors of interest, a relatively rapid throughput
assay will be required, ruling out the use of transgenic or
knockout mice. Therefore, to demonstrate that functional
information on the role in determining mammary cell
fate of the transcriptional regulators identified in this
study can be relatively rapidly generated, and to provide at
the same time the first data required for this modelling,Page 20 of 28
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group of the Sry-related, high mobility group box tran-
scription factor family, Sox6 has two dimerisation
domains and the HMG box domain, but no transactiva-
tion or transrepression domains [52]. Its action as an acti-
vator or repressor of transcription depends, therefore, on
its binding partners [52] and it has been shown both to
repress specification and differentiation of oligodendro-
cytes during gliagenesis [76] and promote differentiation
and maturation of chondrocytes during skeletogenesis
[52,77]. Sox6 has been shown to be upregulated in the
mammary gland by 2-methoxyestradiol treatment [78]
but its role in mammary differentiation has not been pre-
viously investigated.
In this, study, Sox6 was specifically expressed in the
luminal ER- cells and was undetectable in the basal and
luminal ER+ cells. Over-expression of Sox6 in vitro
caused an increase in Krt18 luminal marker gene
expression and a slight, but significant increase in Esr1
expression. It did not change Krt14 gene expression.
However, staining of the cells with antibodies to either
K14 or K18 showed that while control primary mam-
mary cells in short-term culture promiscuously
expressed both K14 and K18 (as previously described)
[59-61], Sox6 over-expressing cells were K18 positive
but K14 negative. Therefore, Sox6 over-expression
maintained the mammary epithelial cells in the lumi-
nal phenotype and prevented promiscuous K14 protein
expression. Cleared fat pad transplant of Sox6 over-
expressing primary cells mixed with wild-type cells
failed to generate extensive GFP+ outgrowths, suggest-
ing that Sox6 over-expression may block transplanta-
tion activity. However, rare GFP+ cells could be detected
in cells isolated from Sox6 transplanted fat pads and
analysed by flow cytometry. The phenotype of these
rare cells was biased toward the luminal ER+ popula-
tion. It is unlikely that this was due to transduction of
different cell populations by the control and Sox6
viruses, as viral tropism is determined by envelope pro-
teins and these are coded by the viral packaging plas-
mids, which were identical for the two viruses. The
small numbers of cells which could be detected and the
caveats associated with over-expression studies mean
that caution must be exercised in interpreting these
data. However, they are consistent with the in vitro data
that Sox6 is involved in promoting or maintaining a dif-
ferentiated luminal phenotype, a corollary of which is
that it blocks stem cell behaviour (transplantation). A
more detailed understanding of the function and mech-
anism of Sox6 action in the mammary epithelium must
await knockdown and inducible over-expression stud-
ies. Nevertheless, our data are the first to suggest that
Sox6 has a role in cell fate determination in the mam-
mary epithelium.
Conclusion
This transcriptome analysis of mammary epithelial cell
subpopulations has provided a framework for future stud-
ies of normal mammary epithelial cell homeostasis and
the molecular pathology of breast disease. First, it has con-
firmed the existence of distinct luminal epithelial cell lin-
eages with distinct gene expression patterns. Second, it has
identified a novel functional specialisation within the
mammary epithelium, that of non-professional immune
cell. Third, it has highlighted the complexity of the poten-
tial paracrine interactions occurring within the mammary
gland. Fourth, it has identified cell-type specific transcrip-
tional regulators with potential roles in mammary epithe-
lial cell lineage specification and fate determination and
has shown how these factors are likely to operate in a
complex network. Last, it has shown that one of the fac-
tors identified, Sox6, may be a determinant of luminal cell
fate in the mammary epithelium. Future studies will use
these data to explore the contribution of the three epithe-
lial cell types to different tumour phenotypes. They will
also focus on the role of the transcription factor network
in cell fate choice and cellular homeostasis to model how
perturbations in this network may lead to cancer.
Methods
Preparation and flow cytometry of single mammary cell 
suspensions
All animal work was carried out under UK Home Office
project and personal licences following local ethical
approval and in accordance with local and national guide-
lines. Fourth mammary fat pads were harvested from 10
week old virgin FVB mice. Single mammary cells suspen-
sions were prepared as described [4,5]. Mammary cell sus-
pensions at 106 cells/ml were stained with anti-CD24-
FITC (clone M1/69, BD Biosciences, Oxford, UK, 0.5 μg/
ml), anti-CD45-PE-Cy5 (clone 30-F11, BD Biosciences,
0.25 μg/ml) and anti-Sca-1-PE (clone D7, BD Biosciences,
0.5 μg/ml) as described [4,5]. For anti-CD14 and CD61
staining, cells were stained with anti-CD14-PE (clone
rmC5-3, BD Biosciences, 1.0 μg/ml), anti-CD61-FITC
(clone 2C9.G2, BD Biosciences, 2.5 μg/ml), anti-CD24-
PE-Cy5 (clone M1/69, eBioscience, Insight Biotechnology
Limited, London, UK, 0.6 μg/ml), anti-Sca-1-APC (clone
D7, eBioscience, 1.0 μg/ml) and anti-CD45-PE-Cy7
(clone 30-F11, BD Biosciences, 1.0 μg/ml). For analysis of
fat pads transplanted with lentivirus-transduced cells,
anti-CD24-PE-Cy5, anti-Sca-1-PE and anti-CD45-PE-Cy7
were used. Cells were sorted at low pressure (20 psi using
a 100 μm nozzle) on a FACSAria (Becton Dickenson,
Oxford, UK) equipped with violet (404 nm), blue (488
nm), green (532 nm), yellow (561 nm) and red (635 nm)
lasers. Both cell sample and collection tubes were main-
tained at 4°C. Single stained samples were used as com-
pensation controls. Dead cells, CD45+ leukocytes and
non-single cells were excluded as described [4,5].Page 21 of 28
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isolated mammary epithelial cells
Freshly sorted mammary epithelial subpopulations were
resuspended in RLT buffer (Qiagen, Crawley, West Sussex,
UK) and stored at -80°C until required for RNA extrac-
tion. Total RNA was extracted using a RNeasy MinElute Kit
(Qiagen), according to the manufacturers' instructions
from CD24+/Low Sca-1-, CD24+/High Sca-1- and CD24+/High
Sca-1+ cells isolated from three independent preparations
of virgin mammary tissue. RNA quantity and purity was
tested in an Agilent 2100 Bioanalyser (Agilent, Woking-
ham, Berkshire, UK). RNA was converted to cDNA using
an oligo d(T) primer, amplified and biotin labeled using
the Ambion MessageAmp II Biotin Enhanced kit (Applied
Biosystems, Warrington, Cheshire, UK). The samples were
fragmented to 35–200 bp and hybridized to Affymetrix
Mouse Expression MOE430 2.0 arrays http://
www.affymetrix.com for 16 hours at 45°C. The arrays
were washed, labeled using an antibody bound to phyco-
erythrin and scanned according to the manufacturer's pro-
tocols. Primary array data, SAM outputs and normalised
data complying with MIAME standards are available
through ROCK [79].
Bioinformatic analysis
Expression data were normalised and summarised by
robust multi-array analysis (RMA) using the Affymetrix
package in the statistical environment R 2.5 [80]. Probe
sets with a standard deviation > 0.25 were used for a mul-
ticlass Significance Analysis of Microarray (SAM; version 3
Excel add-in) [30] to determine if their mean expression
was different across the three subpopulations. Genes
determined by this analysis to have a relative abundance
of 2 or more in a population were considered characteris-
tic of that population. Clustering analysis was carried out
using CLADIST [81].
Data mining for genes of interest in paracrine signalling
interactions or as transcription factors was carried out by
uploading the lists of genes differentially expressed in the
cell subpopulations into the DAVID Bioinformatics
Resource [82] and searching the SP_PIR_KEYWORDS and
GOTERM_BP_ALL lists.
Network interactions maps were provided by uploading
gene lists into a web-based in-house bioinformatics pack-
age and database, ROCK, developed based on the pSTI-
ING server [81]. Interaction maps generated were
manually curated to ensure no interpolated connecting
genes were inappropriately added (so that, for instance,
ESR1 did not appear as a connecting gene in the basal/
myoepithelial network map).
Quantitative PCR analysis
For quanitative PCR-based gene expression analysis,
cDNA synthesis was carried out using a Sensiscript RT kit
(Qiagen). Up to 50 ng of RNA was transcribed into cDNA
using an oligo dTn primer (Promega, Southampton,
Hampshire, UK) per reaction. 0.5 μl of cDNA was used per
qPCR reaction. Each analysis reaction was performed in
triplicate on fresh RNA samples collected separately to
those used for the microarray analysis. β-Actin was used as
an endogenous control throughout all experimental anal-
yses. Gene expression analysis was performed using Taq-
Man Gene Expression Assays (Applied Biosystems,
Warrington, Chesire, UK) on an ABI Prism 7900HT
sequence detection system (Applied Biosystems) [see
Additional file 21]. Analysis was performed using the Δ-
ΔCt method to determine fold changes ± 95% confidence
limits in gene expression across three independently iso-
lated samples relative to a comparator in a 'round robin'
method in which each population was used in turn as the
comparator. With this method, the data was separately
plotted for each of the two non-comparator populations
against the comparator. The non-comparator population
was used to order the dataset on each graph in descending
levels of relative expression from left to right. The point
after which the differences in expression level between the
two populations ceased to be significant (when the confi-
dence intervals of one population overlap the mean of the
other) [58] was plotted (vertical dotted line). All compa-
rator population genes which fall to the right hand side of
the vertical line in both graphs have similar or elevated
levels of expression in the comparator population com-
pared to both the non-comparator populations. Such
genes were considered to be characteristic of the compara-
tor population. Note that in cases where expression of the
gene being analysed could not be detected in the compa-
rator sample, an artificial Ct value of 40 was assigned
purely to make the comparisons. The gene was still
recorded as undetectable in the presented data.
Lentivirus production
Sox6 cDNA was kindly provided by Veronique Lefebvre
(Cleveland Clinic Lerner Research Institute, Cleveland,
Ohio) in pcDNA3.1 and was subcloned into pWPI lenti-
virus expression vector (Tronolab) [83] by PmeI digest.
Viral supernatants were generated by co-transfection of
the expression vector and two packaging vectors (psPAX2
and pMD2.G) into HEK293T cells. Cells were refed with
fresh medium (Dulbecco's Modified Eagle's Medium,
DMEM; Invitrogen, Paisley, UK) plus 10% foetal calf
serum (FCS; PAA Laboratories, Yeovil, Somerset, UK) after
24 hours. Supernatants were harvested 48 and 72 hours
after transfection and checked for absence of replication-
competent virus. Supernatants were stored at -80°C until
use.
Mammary epithelial cell transduction and transplantation
Freshly isolated primary mouse mammary epithelial cells
were resuspended at 1 × 106 cells/ml in viral supernatant
and plated at 1 ml/well in ultra-low attachment 24-wellPage 22 of 28
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tershire, UK) [84]. After 16 hours, the cells (now in
clumps) were washed and replated in 1:1 DMEM: Ham's
F12 medium (Invitrogen) with 10% foetal calf serum, 10
ug/ml insulin (Sigma), 100 ng/ml epidermal growth fac-
tor (Sigma) and 10 ng/ml cholera toxin (Sigma) (growth
medium) [60] and transferred to ultra-low attachment 6-
well plates (Corning). After a further 24 hours, the major-
ity of the cell clumps were injected into cleared fat pads of
3-week old syngeneic FVB mice as described [4]. A propor-
tion, however, were transferred to glass coverslips and/or
normal tissue culture plastic and maintained in growth
medium under low oxygen culture conditions [59,60] for
one week. After this time, cells on plastic were trypsinized
and flow sorted to isolate GFP+ cells for qPCR analysis.
Cells on coverslips were fixed in 4% paraformaldehyde in
PBS, stained for either keratin 14 (clone LLOO2; Abcam,
Cambridge, UK) or keratin 18 (clone Ks18.04; Progen,
Heidelberg, Germany), expression by standard techniques
[59], counterstained with DAPI and then examined on a
TCS SP2 confocal microscope with an Acousto-Optical
Beam Splitter and lasers exciting at 405, 488, 555 and 633
nm (Leica Microsystems, Milton Keynes, UK).
Analysis of transplanted fat pads
Transplanted fat pads were analysed after eight weeks. Fat
pads were stretched on glass slides and then examined
under epifluorescent illumination and photographed. Fat
pads injected with control transduced cells or cells trans-
duced with Sox6 virus were then processed as separate
batches to single cells as described [4,5], stained for
CD45, CD24 and Sca-1 expression and analysed by flow
cytometry.
Multiple immunofluorescence staining of mouse mammary 
gland sections
The protocol for multicolour immunostaining of paraffin
embedded tissue has been recently described [85]. In
brief, mammary fat pads from ten-week old virgin female
FVB mice were fixed in 4% buffered formalin, overnight.
Following standard processing, antigen retrieval was car-
ried out on 4 μm paraffin-embedded sections by boiling
in 0.01 M citrate buffer, pH 6, for 18 minutes in a micro-
wave (900 W). Sections were then blocked for 1 hour in
MOM mouse Ig blocking reagent (Vector Laboratories,
Peterborough, UK; 9 μl stock MOM Ig blocking reagent in
250 μl TBS) and 30 minutes in DAKO protein block
(DAKO, Ely, Cambridgeshire, UK). Sections were stained
with antibodies against K14 (0.26 μg/ml; mouse IgG3
clone LLOO2; Abcam, Cambridge, UK) and K18 (diluted
1:2 from ready-to-use solution; mouse IgG1 clone
Ks18.04; Progen, Heidelberg, Germany) or keratin 14 and
ER (mouse IgG1 clone 1D5; 1:40 dilution; DAKO), over-
night at 4°C. They were then stained with isotype-specific
goat anti-mouse secondary antibodies conjugated to
Alexa Fluor 488 or 555 fluorochromes, counterstained
with DAPI and mounted in Vectashield (H1000; Vector
Laboratories) mounting medium. Sections were exam-
ined at room temperature on the TCS SP2 confocal micro-
scope. Multicolour images were collected sequentially in
three channels. Images were captured using the Leica sys-
tem and Leica TCS image acquisition software. Co-locali-
sation overlays were generated using TCS software.
Control single stained sections in which either the pri-
mary antibody was left out or the primary antibody was
combined with the wrong secondary antibody showed no
staining.
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Additional material
Additional file 1
qPCR analysis of Krt14, Krt18 and Esr1 expression in mammary epi-
thelial subpopulations. The data describes qPCR analysis of expression of 
Krt14, Krt18 and Esr1 in triplicate independent samples of CD24+/Low 
Sca-1- cells, CD24+/High Sca-1- cells and CD24+/High Sca-1+ cells. Each 
data point is the mean level of expression, ± 95% confidence intervals, 
across the three samples of that population relative to the comparator sam-
ple. A 'round robin' comparison was used as described in the Methods. 
Genes considered to be characteristic of the comparator population are 
indicated next to each pair of graphs. Krt14 expression was undetectable 
in the CD24+/High Sca-1- and CD24+/High Sca-1+ cells. Krt18 expression 
was undetectable in the CD24+/Low Sca-1- cells.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S1.tiff]Page 23 of 28
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Relative expression levels of 2182 Affymetrix probes across three virgin 
mouse mammary epithelial subpopulations. The spreadsheet gives the 
relative expression levels for all differentially expressed probes across all 
three populations. Expression levels are indicated by a relative abundance 
score for each populations. A high positive value indicates expression at a 
high level, a low negative score indicates very low expression levels. The 
Affymetrix probe ID, Gene Symbol and q-value (indicating the % false 
discovery rate) are also indicated.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S2.xls]
Additional file 3
Full heat map and hierarchical cluster analysis of differential gene 
expression across virgin mammary epithelial populations. The image 
shows heat map clustering of differentially expressed genes across the three 
cell populations. Red indicates high expression, green indicates low expres-
sion.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S3.tiff]
Additional file 4
Genes characteristic of basal/myoepithelial cells. The table shows all 
861 genes in the basal/myoepithelial population with an abundance score 
of 2 or more when the 1427 differentially expressed gene set was sorted by 
descending abundance scores in the basal/myoepithelial population. Such 
genes were considered characteristic of the population. Where differential 
gene expression was indicated by more than one probe, an average value 
for each of the contrasts across the probes was calculated. The number of 
probes is indicated.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S4.xls]
Additional file 5
Genes characteristic of luminal ER- cells. The table shows all 326 genes 
in the luminal ER- population with an abundance score of 2 or more when 
the 1427 differentially expressed gene set was sorted by descending abun-
dance scores in the luminal ER- population. Such genes were considered 
characteristic of the population. Where differential gene expression was 
indicated by more than one probe, an average value for each of the con-
trasts across the probes was calculated. The number of probes is indicated.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S5.xls]
Additional file 6
Genes characteristic of luminal ER+ cells. The table shows all 488 genes 
in the luminal ER+ population with an abundance score of 2 or more when 
the 1427 differentially expressed gene set was sorted by descending abun-
dance scores in the luminal ER+ population. Such genes were considered 
characteristic of the population. Where differential gene expression was 
indicated by more than one probe, an average value for each of the con-
trasts across the probes was calculated. The number of probes is indicated.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S6.xls]
Additional file 7
Summarised gene expression microarray and qPCR gene expression 
analysis for 58 test genes. The table shows a comparison between the 
gene expression patterns determined by microarray analysis and those 
determined by qPCR. The gene expression microarray relative abundance 
scores are summarised as follows: --- = -32 to -22, -- = -22 to -12, - = -12 
to -2, +/- = -2 to +2, + = 2 to 12, ++ = 12 to 22, +++ = 22 to 32, ++++ 
= 32 to 42. Where more than one identifier for a gene scored as differen-
tially expressed, the mean score across all the identifiers was used to deter-
mine the summarised microarray score. The summarised score was in turn 
used to define the array-based expression pattern, with a score of +, ++, 
+++ or ++++ indicating that a gene was expressed in a particular popula-
tion. In some cases, the genes were expressed in more than one population. 
The summarised qPCR expression pattern is based upon the patterns of 
gene expression determined from Figure 3. Whether or not the array and 
qPCR based analyses show concordance in their assignment of expression 
patterns is indicated. NDE = no differential expression in microarray. N/
A = comparison cannot be made as qPCR probe failed. *In these compar-
isons, technical failure of the Affymetrix probe cannot ruled out.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S7.xls]
Additional file 8
Comparison of numbers of genes identified in common between basal/
myoepithelial, luminal ER- and luminal ER+ cells and previously pub-
lished datasets. The table compares previously published datasets with the 
subpopulation specific genes identified in the current analysis. Published 
lists of genes [27,28], probes [6] or SAGE tags [29] significantly differ-
entially expressed between mouse basal mammary stem cell enriched/
myoepithelial cells compared to in vitro colony forming cells (luminal 
cells) [6], human CD10- CD44+ basal cells compared to CD24+ luminal 
cells [29] or human CD10+ myoepithelial cells compared to EMA+ lumi-
nal cells [27,28] were condensed to remove multiple probes or tags against 
the same gene and to identify only well-annotated genes. The distribution 
of the differentially expressed genes in the basal/myoepithelial, luminal 
ER- and luminal ER+ gene lists from the current study was then deter-
mined.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S8.xls]
Additional file 9
List of genes common to basal/myoepithelial cells and previously pub-
lished basal or myoepithelial datasets. The table lists those basal/myoep-
ithelial genes found in previously published datasets which were also found 
the basal/myoepithelial population in the current study.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S9.xls]
Additional file 10
List of genes common to luminal cell subpopulations and previously 
published luminal datasets. The table lists those luminal genes found in 
previously published datasets which were also found the luminal popula-
tions in the current study.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S10.xls]Page 24 of 28
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Network interaction map for basal/myoepithelial specific genes. Inter-
action data between basal/myoepithelial specific genes based on physical 
interactions (black lines) and interactions in complexes (brown lines) 
with no interpolated genes used. The nodes are colour coded to indicate 
relative strengths of expression of the gene within the cell population. 
Brighter reds indicate highest levels of expression. Darker reds indicate 
genes less strongly expressed (although still with enriched expression 
within the population compared to the other cell types).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S11.tiff]
Additional file 12
Network interaction map for luminal ER- specific genes. Interaction 
data for luminal ER- specific genes based on physical interactions (solid 
lines) and transcriptional interactions (dashed lines). The nodes are col-
our coded to indicate relative strengths of expression of the gene within the 
cell population. Brighter reds indicate highest levels of expression. Darker 
reds indicate genes less strongly expressed (although still with enriched 
expression within the population compared to the other cell types). White 
nodes indicate interpolated genes used by the network mapping software 
to extend and link the network.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S12.tiff]
Additional file 13
Network interaction map for luminal ER+ specific genes. Interaction 
data for luminal ER+ specific genes based on physical interactions (solid 
lines) and transcriptional interactions (dashed lines). The nodes are col-
our coded to indicate relative strengths of expression of the gene within the 
cell population. Brighter reds indicate highest levels of expression. Darker 
reds indicate genes less strongly expressed (although still with enriched 
expression within the population compared to the other cell types). White 
nodes indicate interpolated genes used by the network mapping software 
to extend and link the network.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S13.tiff]
Additional file 14
Identification of prominent modules of differentially expressed genes 
in the luminal ER- and luminal ER+ networks. The results of the first, 
second and third pass analyses for network modules in the luminal ER- 
and luminal ER+ networks are shown. Rectangular nodes are first pass 
nodes, octagonal nodes are second pass nodes and small green oval nodes 
are third pass nodes. Thick red lines are first pass connections, medium 
size red lines are second pass connections and thin red lines are third pass 
connections. Black rectangles indicate differentially expressed hubs for 
which no modules could be built. Coloured rectangles indicate module 
groupings of differentially expressed genes. Solid lines indicate physical 
interactions, dotted lines transcriptional interactions.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S14.tiff]
Additional file 15
Topology of interaction modules within the luminal ER- network. 
Luminal ER- interaction modules are shown projected on to the luminal 
ER- network. First, second and third pass nodes are indicated as coloured 
rectangular, octagonal and oval nodes respectively. First, second and third 
pass connections are indicated as thick, medium and thin red lines respec-
tively. Solid lines indicate physical interactions, dotted lines transcrip-
tional interactions. The different colourings of the first and second pass 
nodes indicate module groupings of differentially expressed genes. Third 
pass nodes are coloured green.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S15.tiff]
Additional file 16
Topology of interaction modules within the luminal ER+ network. 
Luminal ER+ interaction modules are shown projected on to the luminal 
ER+ network. First, second and third pass nodes are indicated as coloured 
rectangular, octagonal and oval nodes respectively. First, second and third 
pass connections are indicated as thick, medium and thin red lines respec-
tively. Solid lines indicate physical interactions, dotted lines transcrip-
tional interactions. The different colourings of the first and second pass 
nodes indicate module groupings of differentially expressed genes. Third 
pass nodes are coloured green. Black rectangles indicate differentially 
expressed hubs for which no modules could be built.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S16.tiff]
Additional file 17
Network metrics for the luminal ER- and luminal ER+ module subnet-
works. The table gives the values for the parameters describing the lumi-
nal ER- and luminal ER+ networks both with and without the identified 
modules. Network manipulations were performed in Cytoscape [111], 
and the average network clustering <C>, average connectivity <k>, power 
exponent γ and mean shortest path <l> were derived with the Cytoscape 
Random Networks plug-in. Note that due to the highly fragmented nature 
of the non-module subnetwork, the mean shortest path does not constitute 
a reliable metric.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S17.xls]
Additional file 18
List of genes common to mammary cell subpopulations and previously 
published datasets of estrogen-responsive genes. The table lists estrogen-
responsive genes identified in previously published datasets which were 
also found in the mammary epithelial cell subpopulations in the current 
study.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S18.xls]
Additional file 19
Genes with potential roles in lineage selection/cell fate determination 
through paracrine signalling or as transcriptional regulators. The 
table lists those genes from the three populations whose protein products 
have potential roles in intercellular signalling or as transcriptional regula-
tors. *Distribution confirmed by qPCR.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2164-9-591-S19.xls]Page 25 of 28
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